Business Wire

TensorX Reaches $5 Million and Appoints Tim Grant as CEO as Demand for Sovereign AI Accelerates

8.10.2026 11:19:00 EEST | Business Wire | Press release

Share

TensorX, the Irish sovereign AI inference company, has reached $5 million in revenue as demand for private AI infrastructure continues to grow across Europe and beyond. Tim Grant, who joined the company as Executive Chairman in May, has been appointed Chief Executive Officer to lead as its growth accelerates.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261008373051/en/

Tim Grant, Executive Chairman since May, is appointed Chief Executive Officer as the Dublin company serves more than 5,000 paying customers and expands its infrastructure across Europe.

TensorX is a neocloud that delivers inference on open-source AI models using dedicated NVIDIA GPUs with zero data retention, so customer data is not stored, reused or sent outside Europe. Since it began serving customers, the company has raised $10 million in seed funding led by Darius Cubed Ventures.

Over seven months, TensorX’s paying customer base grew to over 5,000, ranging from businesses paying a few euros a month to organisations spending thousands of euros depending on their inference needs. The company has dedicated customers paying for reserved capacity on its platform, including APEX:E3, which is building AI applications for enterprises. September marking the company’s first month in which combined shared and dedicated token usage exceeded 1 trillion tokens.

“Progressive businesses are building real AI powered applications right now and they want access to the most performant open source AI models as they evolve, but they also need control over where their data is processed and the infrastructure that runs it,” said Tim Grant, Chief Executive Officer of TensorX.

“We are seeing that demand translate into real usage and commercial growth. Our focus now is on building out GPU capacity, the team and the infrastructure to support that growth while maintaining the level of control our customers require. We also have plans to enter into other jurisdictions to deliver truly sovereign AI as per client needs in multiple locations around the world.”

Between February and September 2026, monthly token volume on TensorX’s shared inference platform grew from 5.63 billion to 1.1 trillion, a 171-fold increase in seven months, compounding at an average of 108% month on month. Growth was recorded in every month of that period, with September alone adding 451 billion tokens, which was more than the platform processed in its first six months combined.

The growth has been driven by customer acquisition rather than a single workload. Active customer domains increased by more than 1,000 over the same period, while monthly API requests rose from 264,917 to 34.5 million.

“Tim has spent his career building and scaling infrastructure in regulated markets, and he has been working alongside us since May,” said Shane Morton, Founder of TensorX.

“As TensorX enters its next phase of growth, his experience will be invaluable as we scale the business and infrastructure around the demand we are seeing.”

One of TensorX's dedicated customers, APEX:E3, is using the platform to build AI applications for enterprises.

“TensorX turbo charged the output of our development team and enabled us to deploy our own A3 coding assistant. TensorX is simply the only platform we trust with our most sensitive data,” said Usman Khan, CEO, APEX:E3.

Across Europe, it is clear that businesses in regulated sectors including financial services, healthcare and defence are looking to adopt AI while retaining greater control over where their data is processed and how their infrastructure is managed. Accenture found that 62% of European organisations are seeking sovereign AI solutions, rising to 76% in banking, while Gartner expects European spending on sovereign cloud infrastructure to more than triple between 2025 and 2027.

TensorX currently owns its own fleet of 96 NVIDIA B300 GPUs in production in Ireland, with additional 96 GPUs available in Finland. The company is currently finalising an order for a significant increase in its GPU fleet. TensorX has around 20 employees and plans to grow the team in the coming months, scaling to meet client demand.

About TensorX

TensorX is an Irish AI infrastructure company providing private, sovereign inference on dedicated NVIDIA GPUs. With zero data retention and infrastructure in Ireland and Finland, TensorX enables organisations to deploy advanced AI with control over where their workloads are processed and how their data is handled. The company supports open-source models and is backed by Darius Cubed Ventures.

About Tim Grant

Tim Grant is Chief Executive Officer of TensorX and Chairman of APEX:E3, a financial technology company providing multi-asset data analytics and AI-powered tools for financial markets, and TradeLocker, a trading platform connecting traders, brokers and proprietary trading firms. He began his career at UBS, where he became a Managing Director in New York, and went on to lead R3's research lab, run SIX Digital Exchange in Zurich, head Galaxy Digital in Europe and lead Deus X Capital as Chief Executive.

Notes to Editors

  • Tim Grant is available for interview on October 8 and 9. High-resolution photography is available on request.
  • Sources: Accenture, "Europe Seeking Greater AI Sovereignty", November 2025; Gartner, reported by ITPro, February 2026.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261008373051/en/

Contacts

Press contact: Mark O'Toole, Inference, m@inferencehq.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Angel Aligner Unveils Six Innovations for 202711.11.2026 18:23:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel”), a global clear aligner leader, has unveiled six new clinical innovations, including SuperElastic (MC-SE)* aligner material, a Deepbite Solution for significantly expanded indications, and the Adapt-MATMsystem for next generation growth guidance for young patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261110338654/en/ Unveiling Angel's 2027 Innovations. Orthodontists and opinion leaders have long remarked about Angel’s clinical excellence. Orthodontics educator and thought leader Dr. David Sarver said: “In over 4 decades, I’ve never had a parent say I’d be happy if you ensure that my child’s treatment results are average.” Angel is committed to elevating the orthodontic specialty well above the average, especially as more competition and harder referral cases demand outstanding results. Bindu Saran, VP of Product Strategy, added: “Angel was founded by orthodontic profe

Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation11.11.2026 16:58:00 EET | Press release

Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 concluded with agreements and initiatives spanning drug discovery, clinical research, preventive and reproductive health, alongside research and entrepreneurship programmes that will sustain collaboration beyond the Summit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261111545964/en/ The Summit is the annual flagship gathering of Future Health – A Global Initiative by Abu Dhabi, curated and convened by the Department of Health – Abu Dhabi (DoH) together with Founding Partners PureHealth, M42, Institute for Healthier Living Abu Dhabi (IHLAD) and Mubadala Bio. Held from 20–22 October, the Summit attracted more than 17,300 visitors from 85 countries. It brought together health leaders, researchers, policymakers, investors and inn

De' Longhi Group: Record Results for the Quarter, With Revenue Growing by 7.7% and Net Profit Pertaining to the Group Progressing Significantly by 19%11.11.2026 16:58:00 EET | Press release

The Board of Directors of De' Longhi S.p.A. approved the consolidated results1 for the nine months of 2026. In the nine months the Group achieved: revenues for € 2,621.3 million, up by 6.5% with respect to 2025 (+7.7% at constant currency); an adjusted2 Ebitda of € 455.2 million, equal to 17.4% on revenues (vs. 15.8% with respect to last year); a net income pertaining to the Group equal to € 225.8 million (+20.4% with respect to last year); a positive net financial position equal to € 606.0 million. CEO Fabio de' Longhi commented: “The Group delivered its thirteenth consecutive quarter of organic revenue growth, underscoring our proven ability to capitalize on industry opportunities and respond promptly to market evolution, while ensuring consistent performance across both divisions. The professional business recorded a strong acceleration, spanning all geographies and brands, with revenues growth exceeding 35% for both the quarter and the nine-month period, this against an already par

Starr Chile Assigned A Rating from AM Best11.11.2026 15:30:00 EET | Press release

Starr, a global insurance and investment organization, today announced that the global credit rating agency AM Best has assigned Starr International Seguros Generales S.A. (Starr Chile) a Financial Strength Rating of A (Excellent) and a Long-Term Issuer Credit Rating of a+ (Excellent). The outlook for both credit ratings is positive. The rating reflects Starr’s strong balance sheet and Starr Chile’s successful implementation of Starr’s business model. AM Best also cited Starr’s operating performance, a favorable business profile and enterprise risk management as key factors supporting the positive rating. “This strong rating is another important endorsement of Starr’s business model as we continue to build our presence in Latin America,” said Jeff Greenberg, chairman and co-CEO of Starr. “It reflects the financial strength, underwriting discipline and experienced teams that underpin our business around the world, reinforcing the confidence brokers and clients can place in Starr.” Starr

Epinal, Inc. Emerges from Stealth with First-of-Its-Kind Breakthrough Semiconductor Electrochemical Biosensor (SEB) for Detection of Narcotics and Disease Biomarkers in Human Breath in Minutes11.11.2026 15:22:00 EET | Press release

Epinal, Inc., after over six years of under-the-radar development, has officially emerged from stealth mode, introducing a breakthrough Semiconductor Electrochemical Biosensor (SEB) designed to detect narcotics and disease biomarkers directly from human breath in minutes. By combining advanced semiconductors, electrochemical sensing, tailored protein engineering, and artificial intelligence, Epinal has addressed the historical sensitivity, selectivity, scaling, stability, and signal-to-noise limitations that have long bottlenecked biosensors. Epinal’s Semiconductor Electrochemical Biosensor (SEB) will be integrated into the next generation of low cost, disposable, single-use breathalyzer cartridges where the integrity of test results is of utmost importance. In the case of narcotic detection, a rapid, non-invasive, and objective result changes an outcome. End customers for Epinal’s SEB include breathalyzer manufacturers, healthcare, mobile computers & clinical smartphones, handheld bio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye